Today the World Health Organization (WHO) prequalified its first biosimilar medicine – trastuzumab – in a move that could make this expensive, life-saving treatment more affordable and available to women globally. Breast cancer is the most common form of cancer in women. 2.1 million women contracted breast cancer in […]

Cliquez ici pour lire la suite WHO prequalifies first biosimilar medicine to increase worldwide access to life-saving breast cancer treatment